Kunming Longjin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd. Market Capitalization on January 14, 2025: USD 95.03 M

Kunming Longjin Pharmaceutical Co., Ltd. Market Capitalization is USD 95.03 M on January 14, 2025, a -84.27% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Kunming Longjin Pharmaceutical Co., Ltd. 52-week high Market Capitalization is USD 604.12 M on January 15, 2024, which is 535.75% above the current Market Capitalization.
Kunming Longjin Pharmaceutical Co., Ltd. 52-week low Market Capitalization is USD 81.54 M on June 28, 2024, which is -14.19% below the current Market Capitalization.
Kunming Longjin Pharmaceutical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 207.87 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shenzhen Stock Exchange: 002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd.

CEO	Mr. Ya He Li
IPO Date	March 24, 2015
Location	China
Headquarters	NO.789, Lanmao Road
Employees	285
Sector	Health Care
Industries Pharmaceuticals Paper & Forest Products

Description

Kunmig Longjin Pharmaceutical Co., Ltd. develops, produces, and sells natural botanicals and chemical freeze-dried powder injections in China. The company offers Chinese, biochemical, chemical, cardio-cerebral vascular, and digestive system medicines; immune system and first aid medications; and vitamins, minerals, and enteral and parenteral nutrition products. It also engages in the industrial hemp plantation business. The company was founded in 1996 and is headquartered in Kunming, China.

Key trends

Past 5 years